A Baltimore vaccine developer that takes its name from the Latin phrase for "to advance or improve" will be doing just that to its vaccine innovation center near Tarrytown, NY.

During the process, Profectus BioSciences’ center will roughly triple in size as part of an expansion fueled by its acquisition of technologies from Wyeth and the University of Maryland School of Medicine's Institute of Human Virology, as well as plans to launch six Phase 1 studies into the safety and effectiveness of its HIV prime-boost therapeutic vaccine.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try GenomeWeb Premium now.

You may already have institutional access!

Check if I qualify.

Already a GenomeWeb or 360Dx Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

An artificial intelligence-based analysis suggests a third group of ancient hominins likely interbred with human ancestors, according to Popular Mechanics.

In Science this week: reduction in bee phylogenetic diversity, and more.

The New York Times Magazine looks into paleogenomics and how it is revising what's know about human history, but also possibly ignoring lessons learned by archaeologists.

The Economist reports on Synthorx's efforts to use expanded DNA bases they generated to develop a new cancer drug.